Barry's profile was created using:
Sort By:

1-10 of 13 online sources for Barry Deutsch

  • View Online Source
    www.sec.gov/Archives/edgar/data/1289407/0001209191-06-0 - [Cached Version]
    Published on: 2/10/2006    Last Visited: 2/11/2006  

    0001289407 Deutsch Barry M. OVATION PHARMACEUTICALS, INC. FOUR PARKWAY NORTH, SUITE 200 DEERFIELD IL 60015 1 0 0 0

  • View Online Source
    phx.corporate-ir.net/phoenix.zhtml?c=97646&p=irol-newsA - [Cached Version]
    Published on: 5/5/2004    Last Visited: 4/24/2008  

    Bally Total Fitness Names Barry M. Deutsch to Replace Martin Franklin on Its Board of DirectorsBally Total Fitness

    Bally Total Fitness
    ...
    Bally Total Fitness Names Barry M. Deutsch to Replace Martin Franklin on Its Board of Directors

    CHICAGO--(BUSINESS WIRE)--May 5, 2004--Bally Total Fitness Holding Corporation (NYSE: BFT) announced today that it has named Barry M. Deutsch to its Board of Directors and Audit Committee.Mr. Deutsch joins Bally with nearly 20 years of experience in the healthcare, finance and mergers and acquisitions arenas.Mr. Deutsch is presently the chief financial officer at Ovation Pharmaceuticals, a Chicago-based specialty pharmaceutical company.Mr. Deutsch joined Ovation in 2001 and has been instrumental in Ovation's financings and acquisitions.Mr. Deutsch will replace Martin Franklin, who resigned earlier this week, citing time commitments.
    ...
    "We expect the addition of Barry to further strengthen our Board of Directors," said Paul Toback, Bally Total Fitness' chairman, president, and chief executive officer.
    ...
    Deutsch said, "I have been particularly impressed with what the Bally team has accomplished in the past 16 months.
    ...
    About Barry M. Deutsch:

    Prior to joining Ovation Pharmaceuticals, Mr. Deutsch was a healthcare investment banker with Vector Securities International and Prudential Vector Healthcare Group where he assisted companies in the life sciences industry in raising capital and evaluating and negotiating mergers, acquisitions, and strategic alliances.Mr. Deutsch joined Vector Securities shortly after the firm was formed and, for the next 12 years, was a key contributor to the firm's growth that culminated in the sale of the firm to Prudential Securities and the creation of Prudential Vector Healthcare.Mr. Deutsch has significant experience working with large healthcare companies on acquisitions and divestitures, as well as experience with specialty pharmaceutical and biotechnology organizations.

    Prior to joining Vector Securities, Mr. Deutsch was an Analyst in the corporate finance group of Salomon Brothers.Mr. Deutsch is a Certified Public Accountant, and he received an MBA degree from the Kellogg Graduate School of Management at Northwestern University and a BSE degree from the Wharton School of the University of Pennsylvania.Mr. Deutsch is 41 years old.

  • View Online Source
    www.sec.gov/Archives/edgar/data/1062982/0000950137-06-0 - [Cached Version]
    Published on: 6/27/2006    Last Visited: 6/28/2006  

    Barry M. Deutsch

    Director
    ...
    Barry M. Deutsch has served as a director since May 2004.Mr. Deutsch is the Chief Financial Officer and Vice President of Business Development of Ovation Pharmaceuticals, Inc., a fully-integrated pharmaceutical company focused on specialty therapeutic areas.Prior to that, Mr. Deutsch served as Director, Corporate Finance of Prudential Vector Healthcare Group, a unit of Prudential Securities Incorporated, where he served as an investment banker specializing in health care industry transactions.Mr. Deutsch is a Certified Public Accountant.
    ...
    Currently, Eric Langshur, Charles J. Burdick and Barry M. Deutsch serve as members of the Audit Committee.
    ...
    Our Board has determined that each member of the Audit Committee is independent, as that term is defined in the Exchange Act, and that Mr. Deutsch is also an "audit committee financial expert" as defined by the SEC.

  • View Online Source
    phx.corporate-ir.net/phoenix.zhtml?c=97646&p=irol-newsA - [Cached Version]
    Published on: 5/5/2004    Last Visited: 9/8/2007  

    Bally Total Fitness Names Barry M. Deutsch to Replace Martin Franklin on Its Board of Directors

    CHICAGO--(BUSINESS WIRE)--May 5, 2004--Bally Total Fitness Holding Corporation (NYSE: BFT) announced today that it has named Barry M. Deutsch to its Board of Directors and Audit Committee.Mr. Deutsch joins Bally with nearly 20 years of experience in the healthcare, finance and mergers and acquisitions arenas.Mr. Deutsch is presently the chief financial officer at Ovation Pharmaceuticals, a Chicago-based specialty pharmaceutical company.Mr. Deutsch joined Ovation in 2001 and has been instrumental in Ovation's financings and acquisitions.Mr. Deutsch will replace Martin Franklin, who resigned earlier this week, citing time commitments.
    ...
    "We expect the addition of Barry to further strengthen our Board of Directors," said Paul Toback, Bally Total Fitness' chairman, president, and chief executive officer.
    ...
    Deutsch said, "I have been particularly impressed with what the Bally team has accomplished in the past 16 months.
    ...
    About Barry M. Deutsch:

    Prior to joining Ovation Pharmaceuticals, Mr. Deutsch was a healthcare investment banker with Vector Securities International and Prudential Vector Healthcare Group where he assisted companies in the life sciences industry in raising capital and evaluating and negotiating mergers, acquisitions, and strategic alliances.Mr. Deutsch joined Vector Securities shortly after the firm was formed and, for the next 12 years, was a key contributor to the firm's growth that culminated in the sale of the firm to Prudential Securities and the creation of Prudential Vector Healthcare.Mr. Deutsch has significant experience working with large healthcare companies on acquisitions and divestitures, as well as experience with specialty pharmaceutical and biotechnology organizations.

    Prior to joining Vector Securities, Mr. Deutsch was an Analyst in the corporate finance group of Salomon Brothers.Mr. Deutsch is a Certified Public Accountant, and he received an MBA degree from the Kellogg Graduate School of Management at Northwestern University and a BSE degree from the Wharton School of the University of Pennsylvania.Mr. Deutsch is 41 years old.

  • View Online Source
    www.ovationpharma.com/press_releases_detail.php?article - [Cached Version]
    Published on: 3/15/2004    Last Visited: 4/24/2007  

    • CFO and Vice President of Business Development Barry Deutsch was an investment banker with Vector Securities and Prudential Healthcare Group.

  • View Online Source
    qc.ipo.com/venture/personprofile.asp?p=ipo&personid=649 - [Cached Version]
    Published on: 8/26/2001    Last Visited: 6/9/2002  

    Barry M. Deutsch Chief Financial Officer

    ...
    Barry M. Deutsch

    ...
    Prior to joining Ovation Pharmaceuticals, Mr. Deutsch was a healthcare investment banker with Vector Securities International and Prudential Vector Healthcare Group where he assisted emerging pharmaceutical and biotechnology companies in raising capital and advised life science companies on strategic alliance and merger and acquisition transactions.Mr. Deutsch joined Vector Securities shortly after its formation and, for the next 12 years, was a key contributor to the firm's growth that culminated in the sale of the firm to Prudential Securities and the creation of Prudential Vector Healthcare.Mr. Deutsch has significant experience working with large pharmaceutical organizations on acquisitions and divestitures (e.g. Baxter and Hoffmann-La Roche) as well as experience with specialty pharmaceutical and biotechnology organizations (e.g. Elan, NPS Pharmaceuticals and MGI PHARMA).Mr. Deutsch also has significant experience with companies focused on concentrated physician specialty markets such as oncology and central nervous system disorders.Prior to joining Vector Securities, Mr. Deutsch was an Analyst in the corporate finance group of Salomon Brothers.Mr. Deutsch is a Certified Public Accountant.

    Management Positions

    Chief Financial Officer / Vice President, Business Development Ovation Pharmaceuticals, Inc.

  • View Online Source
    ipo.ragingbull.com/venture/personprofile.asp?p=ipo&pers - [Cached Version]
    Published on: 8/8/2001    Last Visited: 5/7/2002  

    Barry M. Deutsch Chief Financial Officer

  • View Online Source
    :::: OVATION Pharmaceuticals | Press Room :::: - [Cached Version]
    Published on: 5/31/2003    Last Visited: 1/27/2007  

    , CFO and Vice President of Business Development Barry Deutsch was an investment banker with Vector Securities and Prudential Healthcare Group.

  • View Online Source
    As - [Cached Version]
    Published on: 11/12/2005    Last Visited: 11/12/2005  

    In a suit filed Friday demanding to inspect Bally records, Emanuel Pearlman , a former Bally consultant who owns 12% of the company , attached high school yearbook photos of CEO Paul Toback and director Barry Deutsch, and pointed out that they were in the Key Club, National Honor Society and on the homecoming committee together at Niles North High School.
    ...
    Mr. Deutsch, CFO at Ovation Pharmaceuticals in Deerfield, didn't return a call. [Jeremy Mullman]

  • View Online Source
    PHARLEX® pharma license exchange - Testimonials - [Cached Version]
    Published on: 4/16/2002    Last Visited: 12/26/2005  

    Mr. Barry M. Deutsch, CFO & VP, Business Development

    Ovation Pharmaceuticals, Inc., USA

Page:  1 2 Next

Wrong Person?

Try these instead
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM16